BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16237957)

  • 1. Tumor initiation inhibition through inhibition COX-1 activity of a traditional Korean herbal prescription, Geiji-Bokryung-Hwan, in human hepatocarcinoma cells.
    Park WH; Lee SK; Oh HK; Bae JY; Kim CH
    Immunopharmacol Immunotoxicol; 2005; 27(3):473-83. PubMed ID: 16237957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Geiji-Bokryung-Hwan on carrageenan-induced inflammation in mice and cyclooxygenase-2 in hepatoma cells of HepG2 and Hep3B.
    Park WH; Joo ST; Park KK; Chang YC; Kim CH
    Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):103-12. PubMed ID: 15106735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity.
    Park WH; Kim KS; Kim KH; Kim DS; Kim CH
    Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits.
    Kim BJ; Kim YK; Park WH; Ko JH; Lee YC; Kim CH
    Int Immunopharmacol; 2003 May; 3(5):723-34. PubMed ID: 12757741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
    Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
    Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats.
    Fukutake M; Miura N; Yamamoto M; Fukuda K; Iijima O; Ishikawa H; Kubo M; Okada M; Komatsu Y; Sasaki H; Wakabayashi K; Ishige A; Amagaya S
    Cancer Lett; 2000 Aug; 157(1):9-14. PubMed ID: 10893436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines.
    Cheng J; Imanishi H; Amuro Y; Hada T
    Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of a traditional Korean herbal formulation, Silsosangami, consisting of seven medicinal herbs: effect on hemolysis, neutrophil function, and gene expressions of iNOS and COX-2.
    Park WH; Kim CH; Lee YC; Kim CH
    Vascul Pharmacol; 2004 Aug; 42(1):7-15. PubMed ID: 15664882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenease-2 and hepatocellular carcinoma: is it a target for prevention?
    DuBois RN
    Clin Cancer Res; 2001 May; 7(5):1110-1. PubMed ID: 11350871
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer.
    Suh SJ; Yoon JW; Lee TK; Jin UH; Kim SL; Kim MS; Kwon DY; Lee YC; Kim CH
    Phytother Res; 2007 Feb; 21(2):135-41. PubMed ID: 17128438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma.
    Ha KT; Kim JK; Kang SK; Kim DW; Lee YC; Kim HM; Kim CH
    Pharmacol Res; 2004 Sep; 50(3):279-85. PubMed ID: 15225671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Korean traditional formulation, Hwaotang, on superoxide generation in human neutrophils, platelet aggregation in human blood, and nitric oxide, prostaglandin E2 production and paw oedema induced by carrageenan in mice.
    Park WH; Park SY; Kim HM; Kim CH
    Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):53-73. PubMed ID: 15106732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of Daesungki-Tang on the invasiveness potential of hepatocellular carcinoma through inhibition of matrix metalloproteinase-2 and -9 activities.
    Ha KT; Kim JK; Lee YC; Kim CH
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):1-6. PubMed ID: 15451302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
    Jang M; Cai L; Udeani GO; Slowing KV; Thomas CF; Beecher CW; Fong HH; Farnsworth NR; Kinghorn AD; Mehta RG; Moon RC; Pezzuto JM
    Science; 1997 Jan; 275(5297):218-20. PubMed ID: 8985016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of Cinnamomi Ramulus-Paeoniae Radix Alba drug pair against sepsis based on integrative pharmacology platform of traditional Chinese medicine].
    Yang QX; Lyu HJ; Wang XB; Jiang L; Zeng N
    Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(13):2691-2700. PubMed ID: 31359679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent chemopreventive agents against pancreatic cancer.
    Nishikawa A; Furukawa F; Lee IS; Tanaka T; Hirose M
    Curr Cancer Drug Targets; 2004 Jun; 4(4):373-84. PubMed ID: 15180502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.